Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 23;13(4):10467–10481. doi: 10.1080/21655979.2022.2060787

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — Expression analysis and clinicopathological characteristics of ZNF268 in clear cell renal cell carcinoma (ccRCC). (a) Expression of ZNF268 in 33 kinds of human cancers based on the TCGA database; among the renal cancer, the KICH referred as kidney chromophobe, KIRC as kidney renal clear cell carcinoma and KIRP as kidney renal papillary cell carcinoma. Expression of ZNF268 in ccRCC tissues and adjacent normal tissues (b), and the matched analysis (c). Expression of ZNF268 in normal tissues of GTEx combined with TCGA and ccRCC tissues (d) and the ROC curve of ZNF268 distinguishing ccRCC tissues (e). (f-j) Relationship between ZNF268 expression and clinicopathological features in ccRCC, including TNM-stage, tumor grade and stage. (k) Kaplan-Meier curves for overall survival, disease-specific survival and progress free interval. (Data represent means ± SD, ns represents no statistical difference, *p < 0.05, **p < 0.01 and ***p < 0.001).